- Home
- ADPT vs EVRI Comparison
ADPT vs EVRI Comparison
Compare ADPT & EVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- EVRI
- Stock Information
- Founded
- ADPT 2009
- EVRI 1998
- Country
- ADPT United States
- EVRI United States
- Employees
- ADPT N/A
- EVRI N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- EVRI Services-Misc. Amusement & Recreation
- Sector
- ADPT Health Care
- EVRI Consumer Discretionary
- Exchange
- ADPT Nasdaq
- EVRI Nasdaq
- Market Cap
- ADPT 1.1B
- EVRI 1.2B
- IPO Year
- ADPT 2019
- EVRI 2005
- Fundamental
- Price
- ADPT $7.52
- EVRI $13.72
- Analyst Decision
- ADPT Strong Buy
- EVRI Hold
- Analyst Count
- ADPT 5
- EVRI 4
- Target Price
- ADPT $9.40
- EVRI $12.83
- AVG Volume (30 Days)
- ADPT 2.2M
- EVRI 1.2M
- Earning Date
- ADPT 05-06-2025
- EVRI 03-03-2025
- Dividend Yield
- ADPT N/A
- EVRI N/A
- EPS Growth
- ADPT N/A
- EVRI N/A
- EPS
- ADPT N/A
- EVRI 0.17
- Revenue
- ADPT $178,957,000.00
- EVRI $757,903,000.00
- Revenue This Year
- ADPT $21.21
- EVRI $7.73
- Revenue Next Year
- ADPT $21.98
- EVRI $2.09
- P/E Ratio
- ADPT N/A
- EVRI $80.65
- Revenue Growth
- ADPT 5.10
- EVRI N/A
- 52 Week Low
- ADPT $2.28
- EVRI $6.37
- 52 Week High
- ADPT $9.01
- EVRI $13.83
- Technical
- Relative Strength Index (RSI)
- ADPT 45.59
- EVRI 58.58
- Support Level
- ADPT $7.11
- EVRI $13.58
- Resistance Level
- ADPT $9.01
- EVRI $13.75
- Average True Range (ATR)
- ADPT 0.57
- EVRI 0.06
- MACD
- ADPT -0.03
- EVRI 0.01
- Stochastic Oscillator
- ADPT 28.88
- EVRI 84.21
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.